IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations
详细信息 查看全文
- 作者：H. Dean Hosgood III (1) (2)
Wing-Yan Au (3)
Hee Nam Kim (4)
Jie Liu (5)
Wei Hu (1)
Jovic Tse (3)
Bao Song (5)
Kit-fai Wong (6)
Je-Jung Lee (7)
Stephen J. Chanock (1)
L. P. Siu (6)
Mark P. Purdue (1)
Min-ho Shin (8)
Jinming Yu (5)
Raymond Liang (3)
Hyeoung-Joon Kim (4) (7)
Nathaniel Rothman (1)
Qing Lan (1) - 关键词：NHL ; DLBCL ; Subtype ; Asia ; IL10 ; TNF
- 刊名：International Journal of Hematology
- 出版年：2013
- 出版时间：June 2013
- 年：2013
- 卷：97
- 期：6
- 页码：793-799
- 全文大小：201KB
- 参考文献：1. Blay J, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot M. Serum interleukin-10 in non-Hodgkin’s lymphoma: a prognostic factor. Blood. 1993;82:2169-4.
2. Breen EC, Boscardin WJ, Detels R, Jacobson LP, Smith MW, O’Brien SJ, Chmiel JS, Rinaldo CR, Lai S, Martínez-Maza O. Non-Hodgkin’s B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter ?92 C/C genotype. Clin Immunol. 2003;109:119-9. CrossRef
3. Cunningham LM, Chapman C, Dunstan R, Bell MC, Joske DJL. Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin’s lymphoma. Leuk Lymphoma. 2003;44:251-. CrossRef
4. Hofmann SR, Ettinger R, Zhou YJ, Gadina M, Lipsky P, Siegel R, Candotti F, O’Shea JJ. Cytokines and their role in lymphoid development, differentiation and homeostasis. Curr Opin Allergy Clin Immunol. 2002;2:495-06. CrossRef
5. Hosgood HD 3rd, Zhang L, Tang X, Vermeulen R, Qiu C, Shen M, Smith MT, Ge Y, Ji Z, Xiong J, He J, Reiss B, Liu S, Xie Y, Guo W, Galvan N, Li L, Hao Z, Rothman N, Huang H, Lan Q. Decreased numbers of CD4(+) naive and effector memory T cells, and CD8(+) naive T cells, are associated with trichloroethylene exposure. Front Oncol. 2011;1:1-.
6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-0. CrossRef
7. Lan Q, Au WY, Chanock S, Tse J, Wong KF, Shen M, Siu LP, Yuenger J, Yeager M, Hosgood HD 3rd, Purdue MP, Liang R, Rothman N. Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong. Eur J Haematol. 2010;85:492-. CrossRef
8. Lan Q, Shen M, Garcia-Rossi D, Chanock S, Zheng T, Berndt S, Puri V, Li G, He X, Welch R, Zahm S, Zhang L, Zhang Y, Smith M, Wang S, Chiu B, Linet M, Hayes R, Rothman N, Yeager M. Genotype frequency and Fst analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations. Immunogenetics. 2007;59:839-2. CrossRef
9. Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, Rappaport SM, Shen M, Alter BP, Wu Y, Kopp W, Waidyanatha S, Rabkin C, Guo W, Chanock S, Hayes RB, Linet M, Kim S, Yin S, Rothman N, Smith MT. Hematotoxicity in workers exposed to low levels of benzene. Science. 2004;306:1774-. CrossRef
10. Meenagh A, Williams F, Ross OA, Patterson C, Gorodezky C, Hammond M, Leheny WA, Middleton D. Frequency of cytokine polymorphisms in populations from Western Europe, Africa, Asia, the Middle East and South America. Hum Immunol. 2002;63:1055-1. CrossRef
11. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84:1-2. CrossRef
12. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, de Sanjose S, Cocco P, Berndt SI, Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta P, Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, Holford TR, Gallagher RP, Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B, Lai A, Spink C, Davis S, Bosch R, Scarpa A, Zhang Y, Severson RK, Yeager M, Chanock S, Nieters A. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol. 2006;7:27-8. CrossRef
13. Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjose S, Hughes AM, Cerhan JR, Skibola DR, Purdue M, Kane E, Lan Q, Foretova L, Schenk M, Spinelli JJ, Slager SL, De Roos AJ, Smith MT, Roman E, Cozen W, Boffetta P, Kricker A, Zheng T, Lightfoot T, Cocco P, Benavente Y, Zhang Y, Hartge P, Linet MS, Becker N, Brennan P, Zhang L, Armstrong B, Smith A, Shiao R, Novak AJ, Maynadie M, Chanock SJ, Staines A, Holford TR, Holly EA, Rothman N, Wang SS. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol. 2010;171:267-6. CrossRef
14. Valente FP, Tan CR, Temple SE, Phipps M, Witt CS, Kaur G, Gut I, McGinn S, Allcock RJ, Chew CS, Price P. The evolution and diversity of TNF block haplotypes in European, Asian and Australian Aboriginal populations. Genes Immun. 2009;10:607-5. CrossRef
15. Wang SS, Slager SL, Brennan P, Holly EA, de Sanjose S, Bernstein L, Boffetta P, Cerhan JR, Maynadie M, Spinelli JJ, Chiu BC, Cocco PL, Mensah F, Zhang Y, Nieters A, Dal ML, Bracci PM, Costantini AS, Vineis P, Severson RK, Roman E, Cozen W, Weisenburger D, Davis S, Franceschi S, La Vecchia C, Foretova L, Becker N, Staines A, Vornanen M, Zheng T, Hartge P. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;109:3479-8. CrossRef
16. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, Coiffier B, Salles G. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin’s lymphoma outcome. Blood. 1998;91:3574-1. - 作者单位：H. Dean Hosgood III (1) (2)
Wing-Yan Au (3)
Hee Nam Kim (4)
Jie Liu (5)
Wei Hu (1)
Jovic Tse (3)
Bao Song (5)
Kit-fai Wong (6)
Je-Jung Lee (7)
Stephen J. Chanock (1)
L. P. Siu (6)
Mark P. Purdue (1)
Min-ho Shin (8)
Jinming Yu (5)
Raymond Liang (3)
Hyeoung-Joon Kim (4) (7)
Nathaniel Rothman (1)
Qing Lan (1)
1. Division of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Bethesda, MD, USA
2. Division of Epidemiology, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Ave., Belfer 1309, Bronx, NY, 10461, USA
3. Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong
4. Genome Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, South Korea
5. Key Laboratory of Radiation Oncology of Shandong Province, Shandong Cancer Hospital and Institute, Jinan, Shandong, China
6. Department of Pathology, Queen Elizabeth Hospital, Hong Kong, Hong Kong
7. Department of Hematology/Oncology, Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju, South Korea
8. Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, South Korea
文摘
Genetic variation in immune-related genes, such as IL10 and TNF, have been associated with the development of non-Hodgkin lymphoma (NHL) in Caucasian populations. To test the hypothesis that IL10 and TNF polymorphisms may be associated with NHL risk in Asian populations, we genotyped 20 single nucleotide polymorphisms (SNPs) within the IL10 and TNF/LTA loci in three independent case–control studies (2635 cases and 4234 controls). IL10 rs1800871, rs1800872, and rs1800896 were genotyped in all three studies, while 5 of the remaining SNPs were genotyped in two studies, and 12 in a single study. IL10 rs1800896 was associated with B cell lymphoma [per-allele odds ratio (OR)?=?1.25, 95?% confidence interval (CI)?1.08-.45; p trend?=?0.003], specifically diffuse large B cell lymphoma (DLBCL) (per-allele OR?=?1.29, 95?% CI?1.08-.53; p trend?=?0.004), as well as T cell lymphoma (per-allele OR?=?1.44, 95?% CI?1.13-.82; p trend?=?0.003). TNF rs1800629, which was genotyped in only two of our studies, was also associated with B cell lymphoma (per-allele OR?=?0.77, 95?% CI?0.64-.91; p trend?=?0.003), specifically DLBCL (per-allele OR?=?0.69, 95?% CI?0.55-.86; p trend?=?0.001). Our findings suggest that genetic variation in IL10 and TNF may also play a role in lymphomagenesis in Asian populations.